Pharma channel feed – Endpoints News

Pharma channel feed

AbbVie in position to become largest pharma by 2028, narrowly edging out Roche — report

4 years ago

Longtime Pfizer vet tapped to replace legendary vaccine researcher Kathrin Jansen

4 years ago

BMS, Mirati fund new Stand Up To Cancer research teams, adding to list of pharma partnerships

4 years ago

Bavarian Nordic continues to increase 2022 revenue projections as monkeypox spreads

4 years ago

Changing course, Pfizer decides to sell off stake in GSK's consumer health spinoff

4 years ago

Talk to your doctor? Pharma TV ads are still spurring patients to action, study finds

4 years ago

Jubilant HollisterStier nets US government contract to increase activity at its growing facility

4 years ago

J&J takes Aurobindo to court over potential Erleada generic

4 years ago

Pharma mergers: FTC and DOJ to explore new ways of enforcing antitrust laws

4 years ago

Novartis' Sandoz founds new initiative to expand biosimilar use more globally

4 years ago

Another 14 generics threaten Eli Lilly's blockbuster chemotherapy Alimta

4 years ago

MarketingRx roundup: Novartis cooks up promo with celeb chef; Pharmas launch annual ASCO social media blitz

4 years ago

Medicare doesn't reduce its 2022 premium hike even as use of Biogen's Alzheimer's drug is sharply curtailed

4 years ago

Speaking of the future: Amazon Alexa and the voice-enabled app market for pharma and healthcare

4 years ago

Covid-19 roundup: Moderna reclaims vaccine marketing rights in Japan; New IP waiver draft

4 years ago

Microcap's effort to take on Eylea with Avastin biosimilar faces significant FDA roadblock

4 years ago

Roche wins new Evrysdi approval for the youngest SMA patients

4 years ago

GSK's ViiV debuts next evolution in HIV med Dovato campaign with new spokespeople and new message

4 years ago

Switzerland to destroy over 600,000 expired doses of Moderna Covid vaccine

4 years ago

ViiV Healthcare looks to make long-acting HIV prevention shot accessible in low- and middle-income countries

4 years ago

Look out, Neulasta: A 5th biosimilar is coming

4 years ago

Roche's CD20xCD3 doesn't beat Genmab at ORR, but sets bar for CR data on lymphoma drug

4 years ago

Pair of ex-HHS counsels criticize bill to 'upend' 180-day exclusivity for first generic drugs

4 years ago

Pile-on over PBMs continues with FTC comments and a new bipartisan Senate bill

4 years ago

First page Previous page 196 197 198199200 201 202 Next page Last page